Ռիսպերիդոն (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ռիսպերիդոն" in Armenian language version.

refsWebsite

Global rank Armenian rank

58nih.gov

4^th place

3^rd place

39doi.org

2^nd place

4^th place

14semanticscholar.org

11^th place

428^th place

10web.archive.org

1^st place

4archive.org

6^th place

2drugs.com

399^th place

102^nd place

2clincalc.com

3,912^th place

1,857^th place

2fda.gov

447^th place

244^th place

1books.google.com

3^rd place

17^th place

1handle.net

102^nd place

2,318^th place

1nps.org.au

low place

5,023^rd place

1alzheimers.org.uk

low place

1medicinescomplete.com

low place

2,314^th place

1worldcat.org

5^th place

10^th place

1harvard.edu

18^th place

38^th place

1psychopharmacologyinstitute.com

low place

1drugbank.ca

4,294^th place

5,404^th place

alzheimers.org.uk

«Antipsychotics and other drug approaches in dementia care | Alzheimer's Society». www.alzheimers.org.uk (անգլերեն). Արխիվացված օրիգինալից 2022 թ․ հունվարի 21-ին. Վերցված է 2022 թ․ մայիսի 14-ին.

archive.org

Glick ID, Correll CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, և այլք: (2011 թ․ դեկտեմբեր). «Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach». The Journal of Clinical Psychiatry. 72 (12): 1616–27. doi:10.4088/JCP.11r06927. PMID 22244023.
Chouinard G, Jones BD (1980 թ․ հունվար). «Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics». The American Journal of Psychiatry. 137 (1): 16–21. doi:10.1176/ajp.137.1.16. PMID 6101522.
Chouinard G, Jones BD, Annable L (1978 թ․ նոյեմբեր). «Neuroleptic-induced supersensitivity psychosis». The American Journal of Psychiatry. 135 (11): 1409–10. doi:10.1176/ajp.135.11.1409. PMID 30291.
Scahill L (2008 թ․ հուլիս). «How do I decide whether or not to use medication for my child with autism? Should I try behavior therapy first?». Journal of Autism and Developmental Disorders. 38 (6): 1197–8. doi:10.1007/s10803-008-0573-7. PMID 18463973. S2CID 20767044.

books.google.com

Schatzberg AF, Nemeroff CB (2009). The American Psychiatric Publishing textbook of psychopharmacology (4th ed.). Washington, D.C.: American Psychiatric Pub. էջ 627. ISBN 9781585623099.

clincalc.com

«The Top 300 of 2020». ClinCalc. Վերցված է 2022 թ․ հոկտեմբերի 7-ին.
«Risperidone - Drug Usage Statistics». ClinCalc. Վերցված է 2022 թ․ հոկտեմբերի 7-ին.

doi.org

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, և այլք: (2013 թ․ սեպտեմբեր). «Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet. 382 (9896): 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
Osser DN, Roudsari MJ, Manschreck T (2013). «The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia». Harvard Review of Psychiatry. 21 (1): 18–40. doi:10.1097/HRP.0b013e31827fd915. PMID 23656760. S2CID 22523977.
Glick ID, Correll CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, և այլք: (2011 թ․ դեկտեմբեր). «Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach». The Journal of Clinical Psychiatry. 72 (12): 1616–27. doi:10.4088/JCP.11r06927. PMID 22244023.
Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S (2011 թ․ հունվար). «Risperidone versus other atypical antipsychotics for schizophrenia». The Cochrane Database of Systematic Reviews (1): CD006626. doi:10.1002/14651858.CD006626.pub2. PMC 4167865. PMID 21249678.
Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S (2011 թ․ ապրիլ). «Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials». Schizophrenia Research. 127 (13): 83–92. doi:10.1016/j.schres.2010.11.020. PMID 21257294. S2CID 2386150.
Lafeuille MH, Dean J, Carter V, Duh MS, Fastenau J, Dirani R, Lefebvre P (2014 թ․ օգոստոս). «Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia». Current Medical Research and Opinion. 30 (8): 1643–55. doi:10.1185/03007995.2014.915211. PMID 24730586. S2CID 24814527.
Nielsen J, Jensen SO, Friis RB, Valentin JB, Correll CU (2015 թ․ մայիս). «Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study». Schizophrenia Bulletin. 41 (3): 627–36. doi:10.1093/schbul/sbu128. PMC 4393684. PMID 25180312.
Muralidharan K, Ali M, Silveira LE, Bond DJ, Fountoulakis KN, Lam RW, Yatham LN (2013 թ․ սեպտեմբեր). «Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials». Journal of Affective Disorders. 150 (2): 408–14. doi:10.1016/j.jad.2013.04.032. PMID 23735211.
Nivoli AM, Murru A, Goikolea JM, Crespo JM, Montes JM, González-Pinto A, և այլք: (2012 թ․ հոկտեմբեր). «New treatment guidelines for acute bipolar mania: a critical review». Journal of Affective Disorders. 140 (2): 125–41. doi:10.1016/j.jad.2011.10.015. PMID 22100133.
Yildiz A, Vieta E, Leucht S, Baldessarini RJ (2011 թ․ հունվար). «Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials». Neuropsychopharmacology. 36 (2): 375–89. doi:10.1038/npp.2010.192. PMC 3055677. PMID 20980991.
Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP (2013). «Pharmacotherapy of bipolar disorder in children and adolescents: an update». Revista Brasileira de Psiquiatria. 35 (4): 393–405. doi:10.1590/1516-4446-2012-0999. PMID 24402215.
Gitlin M, Frye MA (2012 թ․ մայիս). «Maintenance therapies in bipolar disorders». Bipolar Disorders. 14 (Suppl 2): 51–65. doi:10.1111/j.1399-5618.2012.00992.x. PMID 22510036. S2CID 21101054.
Gigante AD, Lafer B, Yatham LN (2012 թ․ մայիս). «Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder». CNS Drugs. 26 (5): 403–20. doi:10.2165/11631310-000000000-00000. PMID 22494448. S2CID 2786921.
Jesner OS, Aref-Adib M, Coren E (2007 թ․ հունվար). «Risperidone for autism spectrum disorder». The Cochrane Database of Systematic Reviews. 2010 (1): CD005040. doi:10.1002/14651858.CD005040.pub2. PMC 9022437. PMID 17253538.
Kirino E (2014). «Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children». Clinical Medicine Insights. Pediatrics. 8: 17–30. doi:10.4137/CMPed.S8304. PMC 4051788. PMID 24932108.
Sharma A, Shaw SR (2012). «Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis». Journal of Pediatric Health Care. 26 (4): 291–9. doi:10.1016/j.pedhc.2011.02.008. PMID 22726714.
McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J (2011 թ․ մայիս). «A systematic review of medical treatments for children with autism spectrum disorders». Pediatrics. 127 (5): e1312–21. doi:10.1542/peds.2011-0427. PMID 21464191. S2CID 2903864.
Dove D, Warren Z, McPheeters ML, Taylor JL, Sathe NA, Veenstra-VanderWeele J (2012 թ․ հոկտեմբեր). «Medications for adolescents and young adults with autism spectrum disorders: a systematic review». Pediatrics. 130 (4): 717–26. doi:10.1542/peds.2012-0683. PMC 4074627. PMID 23008452.
Maher AR, Theodore G (2012 թ․ հունիս). «Summary of the comparative effectiveness review on off-label use of atypical antipsychotics». Journal of Managed Care Pharmacy. 18 (5 Suppl B): S1–20. doi:10.18553/jmcp.2012.18.s5-b.1. PMID 22784311.
Dold M, Aigner M, Lanzenberger R, Kasper S (2013 թ․ ապրիլ). «Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials». The International Journal of Neuropsychopharmacology. 16 (3): 557–74. doi:10.1017/S1461145712000740. PMID 22932229.
Eapen V, Gururaj AK (2005). «Risperidone treatment in 12 children with developmental disorders and attention-deficit/hyperactivity disorder». Primary Care Companion to the Journal of Clinical Psychiatry. 7 (5): 221–224. doi:10.4088/pcc.v07n0502. PMC 1257406. PMID 16308577.
Armenteros JL, Lewis JE, Davalos M (2007 թ․ մայիս). «Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study». Journal of the American Academy of Child and Adolescent Psychiatry. 46 (5): 558–565. doi:10.1097/chi.0b013e3180323354. PMID 17450046.
Biederman J, Hammerness P, Doyle R, Joshi G, Aleardi M, Mick E (2008 թ․ փետրվար). «Risperidone treatment for ADHD in children and adolescents with bipolar disorder». Neuropsychiatric Disease and Treatment. 4 (1): 203–207. doi:10.2147/ndt.s1992. PMC 2515893. PMID 18728799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Hasnain M, Vieweg WV, Hollett B (2012 թ․ հուլիս). «Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians». Postgraduate Medicine. 124 (4): 154–67. doi:10.3810/pgm.2012.07.2577. PMID 22913904. S2CID 39697130.
Divac N, Prostran M, Jakovcevski I, Cerovac N (2014). «Second-generation antipsychotics and extrapyramidal adverse effects». BioMed Research International. 2014: 656370. doi:10.1155/2014/656370. PMC 4065707. PMID 24995318.
Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, և այլք: (2020 թ․ հունվար). «Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis». The Lancet. Psychiatry. 7 (1): 64–77. doi:10.1016/S2215-0366(19)30416-X. PMC 7029416. PMID 31860457.
Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (2004 թ․ դեկտեմբեր). «The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein». The International Journal of Neuropsychopharmacology. 7 (4): 415–419. doi:10.1017/S1461145704004390. PMID 15683552.
Gurley BJ, Swain A, Williams DK, Barone G, Battu SK (2008 թ․ հուլիս). «Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics». Molecular Nutrition & Food Research. 52 (7): 772–779. doi:10.1002/mnfr.200700081. PMC 2562898. PMID 18214850.
Chouinard G, Jones BD (1980 թ․ հունվար). «Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics». The American Journal of Psychiatry. 137 (1): 16–21. doi:10.1176/ajp.137.1.16. PMID 6101522.
Miller R, Chouinard G (1993 թ․ նոյեմբեր). «Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia». Biological Psychiatry. 34 (10): 713–38. doi:10.1016/0006-3223(93)90044-E. PMID 7904833. S2CID 2405709.
Chouinard G, Jones BD, Annable L (1978 թ․ նոյեմբեր). «Neuroleptic-induced supersensitivity psychosis». The American Journal of Psychiatry. 135 (11): 1409–10. doi:10.1176/ajp.135.11.1409. PMID 30291.
Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, և այլք: (2005 թ․ մարտ). «Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis». Proceedings of the National Academy of Sciences of the United States of America. 102 (9): 3513–8. Bibcode:2005PNAS..102.3513S. doi:10.1073/pnas.0409766102. PMC 548961. PMID 15716360.
Moncrieff J (2006 թ․ հուլիս). «Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse». Acta Psychiatrica Scandinavica. 114 (1): 3–13. doi:10.1111/j.1600-0447.2006.00787.x. PMID 16774655. S2CID 6267180.
Abou El-Magd RM, Park HK, Kawazoe T, Iwana S, Ono K, Chung SP, և այլք: (2010 թ․ հուլիս). «The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia». Journal of Psychopharmacology. 24 (7): 1055–67. doi:10.1177/0269881109102644. PMID 19329549. S2CID 39050369.
Marchese G, Casu G, Casti P, Spada GP, Pani L (2009 թ․ հոկտեմբեր). «Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats». European Journal of Pharmacology. 620 (1–3): 36–41. doi:10.1016/j.ejphar.2009.07.024. PMID 19664616.
Banks ML, Blough BE (2015 թ․ օգոստոս). «Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys». Neuropsychopharmacology. 40 (9): 2198–2206. doi:10.1038/npp.2015.63. PMC 4613609. PMID 25742872. S2CID 5148588.
Hecht EM, Landy DC (2012 թ․ փետրվար). «Alpha-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis». Schizophrenia Research. 134 (2–3): 202–6. doi:10.1016/j.schres.2011.11.030. PMID 22169246. S2CID 36119981.
Brauner JM, Hessler S, Groemer TW, Alzheimer C, Huth T (2014 թ․ ապրիլ). «Risperidone inhibits voltage-gated sodium channels». European Journal of Pharmacology. 728: 100–106. doi:10.1016/j.ejphar.2014.01.062. PMID 24508524.
Scahill L (2008 թ․ հուլիս). «How do I decide whether or not to use medication for my child with autism? Should I try behavior therapy first?». Journal of Autism and Developmental Disorders. 38 (6): 1197–8. doi:10.1007/s10803-008-0573-7. PMID 18463973. S2CID 20767044.

drugbank.ca

«The DrugBank database». Արխիվացված օրիգինալից 2011 թ․ նոյեմբերի 17-ին.

drugs.com

«Risperidone». The American Society of Health-System Pharmacists. Արխիվացված օրիգինալից 2015 թ․ դեկտեմբերի 2-ին. Վերցված է 2015 թ․ դեկտեմբերի 1-ին.
«Respiridone». The American Society of Health-System Pharmacists. Արխիվացված օրիգինալից 2011 թ․ ապրիլի 13-ին. Վերցված է 2011 թ․ ապրիլի 3-ին.

fda.gov

accessdata.fda.gov

«Electronic Orange Book». Food and Drug Administration. 2007 թ․ ապրիլ. Արխիվացված օրիգինալից 2007 թ․ օգոստոսի 19-ին. Վերցված է 2007 թ․ մայիսի 24-ին.

fda.gov

«FDA approves the first drug to treat irritability associated with autism, Risperdal» (Press release). FDA. 2006 թ․ հոկտեմբերի 6. Արխիվացված օրիգինալից 2009 թ․ օգոստոսի 28-ին. Վերցված է 2009 թ․ օգոստոսի 14-ին.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

harvard.edu

ui.adsabs.harvard.edu

Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, և այլք: (2005 թ․ մարտ). «Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis». Proceedings of the National Academy of Sciences of the United States of America. 102 (9): 3513–8. Bibcode:2005PNAS..102.3513S. doi:10.1073/pnas.0409766102. PMC 548961. PMID 15716360.

medicinescomplete.com

Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press http://www.medicinescomplete.com Արխիվացված 10 Հունիս 2021 Wayback Machine [Accessed on 2 February 2020]

nih.gov

pubmed.ncbi.nlm.nih.gov

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, և այլք: (2013 թ․ սեպտեմբեր). «Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet. 382 (9896): 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
Osser DN, Roudsari MJ, Manschreck T (2013). «The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia». Harvard Review of Psychiatry. 21 (1): 18–40. doi:10.1097/HRP.0b013e31827fd915. PMID 23656760. S2CID 22523977.
Barry SJ, Gaughan TM, Hunter R (2012 թ․ հունիս). «Schizophrenia». BMJ Clinical Evidence. 2012. PMC 3385413. PMID 23870705.
Glick ID, Correll CU, Altamura AC, Marder SR, Csernansky JG, Weiden PJ, և այլք: (2011 թ․ դեկտեմբեր). «Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach». The Journal of Clinical Psychiatry. 72 (12): 1616–27. doi:10.4088/JCP.11r06927. PMID 22244023.
Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S (2011 թ․ հունվար). «Risperidone versus other atypical antipsychotics for schizophrenia». The Cochrane Database of Systematic Reviews (1): CD006626. doi:10.1002/14651858.CD006626.pub2. PMC 4167865. PMID 21249678.
Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S (2011 թ․ ապրիլ). «Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials». Schizophrenia Research. 127 (13): 83–92. doi:10.1016/j.schres.2010.11.020. PMID 21257294. S2CID 2386150.
Lafeuille MH, Dean J, Carter V, Duh MS, Fastenau J, Dirani R, Lefebvre P (2014 թ․ օգոստոս). «Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia». Current Medical Research and Opinion. 30 (8): 1643–55. doi:10.1185/03007995.2014.915211. PMID 24730586. S2CID 24814527.
Nielsen J, Jensen SO, Friis RB, Valentin JB, Correll CU (2015 թ․ մայիս). «Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study». Schizophrenia Bulletin. 41 (3): 627–36. doi:10.1093/schbul/sbu128. PMC 4393684. PMID 25180312.
Muralidharan K, Ali M, Silveira LE, Bond DJ, Fountoulakis KN, Lam RW, Yatham LN (2013 թ․ սեպտեմբեր). «Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials». Journal of Affective Disorders. 150 (2): 408–14. doi:10.1016/j.jad.2013.04.032. PMID 23735211.
Nivoli AM, Murru A, Goikolea JM, Crespo JM, Montes JM, González-Pinto A, և այլք: (2012 թ․ հոկտեմբեր). «New treatment guidelines for acute bipolar mania: a critical review». Journal of Affective Disorders. 140 (2): 125–41. doi:10.1016/j.jad.2011.10.015. PMID 22100133.
Yildiz A, Vieta E, Leucht S, Baldessarini RJ (2011 թ․ հունվար). «Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials». Neuropsychopharmacology. 36 (2): 375–89. doi:10.1038/npp.2010.192. PMC 3055677. PMID 20980991.
Peruzzolo TL, Tramontina S, Rohde LA, Zeni CP (2013). «Pharmacotherapy of bipolar disorder in children and adolescents: an update». Revista Brasileira de Psiquiatria. 35 (4): 393–405. doi:10.1590/1516-4446-2012-0999. PMID 24402215.
Gitlin M, Frye MA (2012 թ․ մայիս). «Maintenance therapies in bipolar disorders». Bipolar Disorders. 14 (Suppl 2): 51–65. doi:10.1111/j.1399-5618.2012.00992.x. PMID 22510036. S2CID 21101054.
Gigante AD, Lafer B, Yatham LN (2012 թ․ մայիս). «Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder». CNS Drugs. 26 (5): 403–20. doi:10.2165/11631310-000000000-00000. PMID 22494448. S2CID 2786921.
Jesner OS, Aref-Adib M, Coren E (2007 թ․ հունվար). «Risperidone for autism spectrum disorder». The Cochrane Database of Systematic Reviews. 2010 (1): CD005040. doi:10.1002/14651858.CD005040.pub2. PMC 9022437. PMID 17253538.
Kirino E (2014). «Efficacy and tolerability of pharmacotherapy options for the treatment of irritability in autistic children». Clinical Medicine Insights. Pediatrics. 8: 17–30. doi:10.4137/CMPed.S8304. PMC 4051788. PMID 24932108.
Sharma A, Shaw SR (2012). «Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis». Journal of Pediatric Health Care. 26 (4): 291–9. doi:10.1016/j.pedhc.2011.02.008. PMID 22726714.
McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J (2011 թ․ մայիս). «A systematic review of medical treatments for children with autism spectrum disorders». Pediatrics. 127 (5): e1312–21. doi:10.1542/peds.2011-0427. PMID 21464191. S2CID 2903864.
Dove D, Warren Z, McPheeters ML, Taylor JL, Sathe NA, Veenstra-VanderWeele J (2012 թ․ հոկտեմբեր). «Medications for adolescents and young adults with autism spectrum disorders: a systematic review». Pediatrics. 130 (4): 717–26. doi:10.1542/peds.2012-0683. PMC 4074627. PMID 23008452.
Maher AR, Theodore G (2012 թ․ հունիս). «Summary of the comparative effectiveness review on off-label use of atypical antipsychotics». Journal of Managed Care Pharmacy. 18 (5 Suppl B): S1–20. doi:10.18553/jmcp.2012.18.s5-b.1. PMID 22784311.
Dold M, Aigner M, Lanzenberger R, Kasper S (2013 թ․ ապրիլ). «Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials». The International Journal of Neuropsychopharmacology. 16 (3): 557–74. doi:10.1017/S1461145712000740. PMID 22932229.
Eapen V, Gururaj AK (2005). «Risperidone treatment in 12 children with developmental disorders and attention-deficit/hyperactivity disorder». Primary Care Companion to the Journal of Clinical Psychiatry. 7 (5): 221–224. doi:10.4088/pcc.v07n0502. PMC 1257406. PMID 16308577.
Armenteros JL, Lewis JE, Davalos M (2007 թ․ մայիս). «Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study». Journal of the American Academy of Child and Adolescent Psychiatry. 46 (5): 558–565. doi:10.1097/chi.0b013e3180323354. PMID 17450046.
Biederman J, Hammerness P, Doyle R, Joshi G, Aleardi M, Mick E (2008 թ․ փետրվար). «Risperidone treatment for ADHD in children and adolescents with bipolar disorder». Neuropsychiatric Disease and Treatment. 4 (1): 203–207. doi:10.2147/ndt.s1992. PMC 2515893. PMID 18728799.{{cite journal}}: CS1 սպաս․ չպիտակված ազատ DOI (link)
Hasnain M, Vieweg WV, Hollett B (2012 թ․ հուլիս). «Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians». Postgraduate Medicine. 124 (4): 154–67. doi:10.3810/pgm.2012.07.2577. PMID 22913904. S2CID 39697130.
Divac N, Prostran M, Jakovcevski I, Cerovac N (2014). «Second-generation antipsychotics and extrapyramidal adverse effects». BioMed Research International. 2014: 656370. doi:10.1155/2014/656370. PMC 4065707. PMID 24995318.
Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M, MacGregor T, Jafri SH, Featherstone R, Hartling L (2017 թ․ մարտ). «First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update». Comparative Effectiveness Reviews (184): ES–24. PMID 28749632. Report 17-EHC001-EF. Bookshelf ID: NBK442352. «Compared with FGAs, SGAs may decrease the risk for experiencing any extrapyramidal symptom (EPS). FGAs probably cause lower gains in weight and BMI.»
Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, և այլք: (2020 թ․ հունվար). «Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis». The Lancet. Psychiatry. 7 (1): 64–77. doi:10.1016/S2215-0366(19)30416-X. PMC 7029416. PMID 31860457.
Wang JS, Ruan Y, Taylor RM, Donovan JL, Markowitz JS, DeVane CL (2004 թ․ դեկտեմբեր). «The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein». The International Journal of Neuropsychopharmacology. 7 (4): 415–419. doi:10.1017/S1461145704004390. PMID 15683552.
Gurley BJ, Swain A, Williams DK, Barone G, Battu SK (2008 թ․ հուլիս). «Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics». Molecular Nutrition & Food Research. 52 (7): 772–779. doi:10.1002/mnfr.200700081. PMC 2562898. PMID 18214850.
Chouinard G, Jones BD (1980 թ․ հունվար). «Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics». The American Journal of Psychiatry. 137 (1): 16–21. doi:10.1176/ajp.137.1.16. PMID 6101522.
Miller R, Chouinard G (1993 թ․ նոյեմբեր). «Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia». Biological Psychiatry. 34 (10): 713–38. doi:10.1016/0006-3223(93)90044-E. PMID 7904833. S2CID 2405709.
Chouinard G, Jones BD, Annable L (1978 թ․ նոյեմբեր). «Neuroleptic-induced supersensitivity psychosis». The American Journal of Psychiatry. 135 (11): 1409–10. doi:10.1176/ajp.135.11.1409. PMID 30291.
Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, և այլք: (2005 թ․ մարտ). «Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis». Proceedings of the National Academy of Sciences of the United States of America. 102 (9): 3513–8. Bibcode:2005PNAS..102.3513S. doi:10.1073/pnas.0409766102. PMC 548961. PMID 15716360.
Moncrieff J (2006 թ․ հուլիս). «Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse». Acta Psychiatrica Scandinavica. 114 (1): 3–13. doi:10.1111/j.1600-0447.2006.00787.x. PMID 16774655. S2CID 6267180.
Abou El-Magd RM, Park HK, Kawazoe T, Iwana S, Ono K, Chung SP, և այլք: (2010 թ․ հուլիս). «The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia». Journal of Psychopharmacology. 24 (7): 1055–67. doi:10.1177/0269881109102644. PMID 19329549. S2CID 39050369.
Cohen LJ (1994). «Risperidone». Pharmacotherapy. 14 (3): 253–265. PMID 7524043.
Marchese G, Casu G, Casti P, Spada GP, Pani L (2009 թ․ հոկտեմբեր). «Evaluation of amphetamine-induced hyperlocomotion and catalepsy following long-acting risperidone administration in rats». European Journal of Pharmacology. 620 (1–3): 36–41. doi:10.1016/j.ejphar.2009.07.024. PMID 19664616.
Banks ML, Blough BE (2015 թ․ օգոստոս). «Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys». Neuropsychopharmacology. 40 (9): 2198–2206. doi:10.1038/npp.2015.63. PMC 4613609. PMID 25742872. S2CID 5148588.
Hecht EM, Landy DC (2012 թ․ փետրվար). «Alpha-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis». Schizophrenia Research. 134 (2–3): 202–6. doi:10.1016/j.schres.2011.11.030. PMID 22169246. S2CID 36119981.
Brauner JM, Hessler S, Groemer TW, Alzheimer C, Huth T (2014 թ․ ապրիլ). «Risperidone inhibits voltage-gated sodium channels». European Journal of Pharmacology. 728: 100–106. doi:10.1016/j.ejphar.2014.01.062. PMID 24508524.
Scahill L (2008 թ․ հուլիս). «How do I decide whether or not to use medication for my child with autism? Should I try behavior therapy first?». Journal of Autism and Developmental Disorders. 38 (6): 1197–8. doi:10.1007/s10803-008-0573-7. PMID 18463973. S2CID 20767044.

nps.org.au

«Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia». NPS MedicineWise (անգլերեն). 2020 թ․ մարտի 19. Արխիվացված օրիգինալից 2022 թ․ մայիսի 14-ին. Վերցված է 2022 թ․ մայիսի 14-ին.

psychopharmacologyinstitute.com

«Psychopharmacology Institute». Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 11-ին. Վերցված է 2022 թ․ մայիսի 15-ին.

semanticscholar.org

api.semanticscholar.org

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, և այլք: (2013 թ․ սեպտեմբեր). «Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis». Lancet. 382 (9896): 951–62. doi:10.1016/S0140-6736(13)60733-3. PMID 23810019. S2CID 32085212.
Osser DN, Roudsari MJ, Manschreck T (2013). «The psychopharmacology algorithm project at the Harvard South Shore Program: an update on schizophrenia». Harvard Review of Psychiatry. 21 (1): 18–40. doi:10.1097/HRP.0b013e31827fd915. PMID 23656760. S2CID 22523977.
Leucht C, Heres S, Kane JM, Kissling W, Davis JM, Leucht S (2011 թ․ ապրիլ). «Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials». Schizophrenia Research. 127 (13): 83–92. doi:10.1016/j.schres.2010.11.020. PMID 21257294. S2CID 2386150.
Lafeuille MH, Dean J, Carter V, Duh MS, Fastenau J, Dirani R, Lefebvre P (2014 թ․ օգոստոս). «Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia». Current Medical Research and Opinion. 30 (8): 1643–55. doi:10.1185/03007995.2014.915211. PMID 24730586. S2CID 24814527.
Gitlin M, Frye MA (2012 թ․ մայիս). «Maintenance therapies in bipolar disorders». Bipolar Disorders. 14 (Suppl 2): 51–65. doi:10.1111/j.1399-5618.2012.00992.x. PMID 22510036. S2CID 21101054.
Gigante AD, Lafer B, Yatham LN (2012 թ․ մայիս). «Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder». CNS Drugs. 26 (5): 403–20. doi:10.2165/11631310-000000000-00000. PMID 22494448. S2CID 2786921.
McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J (2011 թ․ մայիս). «A systematic review of medical treatments for children with autism spectrum disorders». Pediatrics. 127 (5): e1312–21. doi:10.1542/peds.2011-0427. PMID 21464191. S2CID 2903864.
Hasnain M, Vieweg WV, Hollett B (2012 թ․ հուլիս). «Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians». Postgraduate Medicine. 124 (4): 154–67. doi:10.3810/pgm.2012.07.2577. PMID 22913904. S2CID 39697130.
Miller R, Chouinard G (1993 թ․ նոյեմբեր). «Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia». Biological Psychiatry. 34 (10): 713–38. doi:10.1016/0006-3223(93)90044-E. PMID 7904833. S2CID 2405709.
Moncrieff J (2006 թ․ հուլիս). «Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse». Acta Psychiatrica Scandinavica. 114 (1): 3–13. doi:10.1111/j.1600-0447.2006.00787.x. PMID 16774655. S2CID 6267180.
Abou El-Magd RM, Park HK, Kawazoe T, Iwana S, Ono K, Chung SP, և այլք: (2010 թ․ հուլիս). «The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia». Journal of Psychopharmacology. 24 (7): 1055–67. doi:10.1177/0269881109102644. PMID 19329549. S2CID 39050369.
Banks ML, Blough BE (2015 թ․ օգոստոս). «Effects of Environmental Manipulations and Treatment with Bupropion and Risperidone on Choice between Methamphetamine and Food in Rhesus Monkeys». Neuropsychopharmacology. 40 (9): 2198–2206. doi:10.1038/npp.2015.63. PMC 4613609. PMID 25742872. S2CID 5148588.
Hecht EM, Landy DC (2012 թ․ փետրվար). «Alpha-2 receptor antagonist add-on therapy in the treatment of schizophrenia; a meta-analysis». Schizophrenia Research. 134 (2–3): 202–6. doi:10.1016/j.schres.2011.11.030. PMID 22169246. S2CID 36119981.
Scahill L (2008 թ․ հուլիս). «How do I decide whether or not to use medication for my child with autism? Should I try behavior therapy first?». Journal of Autism and Developmental Disorders. 38 (6): 1197–8. doi:10.1007/s10803-008-0573-7. PMID 18463973. S2CID 20767044.

web.archive.org

«Risperidone». The American Society of Health-System Pharmacists. Արխիվացված օրիգինալից 2015 թ․ դեկտեմբերի 2-ին. Վերցված է 2015 թ․ դեկտեմբերի 1-ին.
«Risperdal- risperidone tablet Risperdal M-Tab- risperidone tablet, orally disintegrating Risperdal- risperidone solution». DailyMed. Արխիվացված օրիգինալից 2017 թ․ ապրիլի 30-ին. Վերցված է 2019 թ․ դեկտեմբերի 31-ին.
«Respiridone». The American Society of Health-System Pharmacists. Արխիվացված օրիգինալից 2011 թ․ ապրիլի 13-ին. Վերցված է 2011 թ․ ապրիլի 3-ին.
«Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia». NPS MedicineWise (անգլերեն). 2020 թ․ մարտի 19. Արխիվացված օրիգինալից 2022 թ․ մայիսի 14-ին. Վերցված է 2022 թ․ մայիսի 14-ին.
«Antipsychotics and other drug approaches in dementia care | Alzheimer's Society». www.alzheimers.org.uk (անգլերեն). Արխիվացված օրիգինալից 2022 թ․ հունվարի 21-ին. Վերցված է 2022 թ․ մայիսի 14-ին.
Joint Formulary Committee. British National Formulary (online) London: BMJ Group and Pharmaceutical Press http://www.medicinescomplete.com Արխիվացված 10 Հունիս 2021 Wayback Machine [Accessed on 2 February 2020]
«Psychopharmacology Institute». Արխիվացված օրիգինալից 2020 թ․ նոյեմբերի 11-ին. Վերցված է 2022 թ․ մայիսի 15-ին.
«The DrugBank database». Արխիվացված օրիգինալից 2011 թ․ նոյեմբերի 17-ին.
«Electronic Orange Book». Food and Drug Administration. 2007 թ․ ապրիլ. Արխիվացված օրիգինալից 2007 թ․ օգոստոսի 19-ին. Վերցված է 2007 թ․ մայիսի 24-ին.
«FDA approves the first drug to treat irritability associated with autism, Risperdal» (Press release). FDA. 2006 թ․ հոկտեմբերի 6. Արխիվացված օրիգինալից 2009 թ․ օգոստոսի 28-ին. Վերցված է 2009 թ․ օգոստոսի 14-ին.

worldcat.org

BMJ Group, ed. (2009 թ․ մարտ). «4.2.1». British National Formulary (57 ed.). United Kingdom: Royal Pharmaceutical Society of Great Britain. էջ 192. ISSN 0260-535X. «Withdrawal of antipsychotic drugs after long-term therapy should always be gradual and closely monitored to avoid the risk of acute withdrawal syndromes or rapid relapse.»

Ռիսպերիդոն (Armenian Wikipedia)

alzheimers.org.uk

archive.org

books.google.com

clincalc.com

doi.org

drugbank.ca

drugs.com

fda.gov

accessdata.fda.gov

fda.gov

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

medicinescomplete.com

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

nps.org.au

psychopharmacologyinstitute.com

semanticscholar.org

api.semanticscholar.org

web.archive.org

worldcat.org